The November issue of the VADEMECUM, a weekly business magazine,
included rankings of the top Russian pharmaceutical companies, which had
been compiled by IMS, an international intelligence company.
The magazine’s staff decided to find out how the pharmaceutical market
reform affected the leading manufacturers. The investigation was based
on the IMS’s top pharmaceutical manufacturers’ sales ranking for 2013
and H1 2014. The finalists were the top 50 manufacturers, including the
GEROPHARM Group that ranked 24th. Particular attention was given to the
analysis of the companies’ business transparency. The degree of
transparency was graded via the VADEMECUM’s “star system” traditionally
used by intelligence companies. The maximum number of stars — four — was
awarded to the most transparent companies that had provided complete
information on their businesses. As a result, only six companies out of
the 50 received four stars.The GEROPHARM Group hit the list of the most
open and transparent companies.
GEROFRM also hit another interesting ranking which has a tell-tale
title: “No Strangers Allowed”. GEROPHARM ranked 16th among the top 20
pharmaceutical companies in terms of their proprietary products
manufacture volume. That ranking factored in the manufactures’ financial
statements for 2013 and H1 2014 with respect to the commercial and
public procurement markets.
For the details of the two rankings please see the VADEMECUM nos. 35–36 of November 10, 2014, and the PDF files attached to this story.